The company’s indigenously developed needle-free three-dose COVID-19 vaccine ZyCoV-D was granted emergency use authorisation (EUA) by the drug regulator on Friday
Read More
Chiến lược marketing
Hope to start supply of ZyCoV-D vaccine by mid to end Sept: Zydus Group MD
21
Th8
Th8
